Build Your Comparison

Side-by-side financial analysis
TRNS logo
TRNS
TMO logo
TMO
JPM logo
JPM
DHR logo
DHR
A logo
A
KO logo
KO
Try popular comparisons:

Stock Comparison

TRNS vs TMO vs JPM vs DHR vs A vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TRNS
Transcat, Inc.

Industrial - Distribution

IndustrialsNASDAQ • US
Market Cap$852M
5Y Perf.+252.9%
TMO
Thermo Fisher Scientific Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$174.42B
5Y Perf.+29.5%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
DHR
Danaher Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$127.47B
5Y Perf.+14.9%
A
Agilent Technologies, Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$36.67B
5Y Perf.+46.9%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.61B
5Y Perf.+84.9%

TRNS vs TMO vs JPM vs DHR vs A vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TRNS logoTRNS
TMO logoTMO
JPM logoJPM
DHR logoDHR
A logoA
KO logoKO
IndustryIndustrial - DistributionMedical - Diagnostics & ResearchBanks - DiversifiedMedical - Diagnostics & ResearchMedical - Diagnostics & ResearchBeverages - Non-Alcoholic
Market Cap$852M$174.42B$896.00B$127.47B$36.67B$355.61B
Revenue (TTM)$333M$45.20B$280.33B$24.78B$7.23B$49.28B
Net Income (TTM)$7M$6.86B$57.05B$3.69B$1.41B$13.70B
Gross Margin32.6%39.4%60.0%60.7%53.0%61.7%
Operating Margin4.1%17.8%25.9%21.0%21.5%29.3%
Forward P/E51.9x18.9x14.4x21.3x21.4x25.3x
Total Debt$129M$40.85B$942.38B$18.42B$3.35B$45.49B
Cash & Equiv.$5M$9.86B$343.34B$4.62B$1.79B$10.27B

TRNS vs TMO vs JPM vs DHR vs A vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TRNS
TMO
JPM
DHR
A
KO
StockJun 20Jun 26Return
Transcat, Inc. (TRNS)100352.9+252.9%
Thermo Fisher Scien… (TMO)100129.5+29.5%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
Danaher Corporation (DHR)100114.9+14.9%
Agilent Technologie… (A)100146.9+46.9%
The Coca-Cola Compa… (KO)100184.9+84.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: TRNS vs TMO vs JPM vs DHR vs A vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: KO leads in 3 of 7 categories (6-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. JPMorgan Chase & Co. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. TRNS and DHR also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇KO emerged as the overall leader. Track its performance:
TRNS
Transcat, Inc.
The Growth Play

TRNS ranks third and is worth considering specifically for growth exposure and long-term compounding.

  • Rev growth 19.2%, EPS growth -63.7%, 3Y rev CAGR 12.9%
  • 7.7% 10Y total return vs JPM's 465.8%
  • 19.2% revenue growth vs KO's 1.9%
Best for: growth exposure and long-term compounding
TMO
Thermo Fisher Scientific Inc.
The Healthcare Pick

Among these 6 stocks, TMO doesn't own a clear edge in any measured category.

Best for: healthcare exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • PEG 0.81 vs DHR's 35.21
  • Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
  • +21.8% vs DHR's -11.5%
Best for: income & stability and valuation efficiency
DHR
Danaher Corporation
The Defensive Pick

DHR is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 0.70, Low D/E 35.1%, current ratio 1.87x
  • Beta 0.70, yield 0.7%, current ratio 1.87x
  • Beta 0.70 vs TRNS's 1.35, lower leverage
Best for: sleep-well-at-night and defensive
A
Agilent Technologies, Inc.
The Healthcare Pick

A doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.

Best for: healthcare exposure
KO
The Coca-Cola Company
The Quality Compounder

KO carries the broadest edge in this set and is the clearest fit for quality and dividends.

  • 27.8% margin vs TRNS's 2.0%
  • 2.5% yield, 56-year raise streak, vs DHR's 0.7%, (1 stock pays no dividend)
  • 13.1% ROA vs JPM's 1.3%, ROIC 15.8% vs 4.5%
Best for: quality and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthTRNS logoTRNS19.2% revenue growth vs KO's 1.9%
ValueJPM logoJPMLower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Quality / MarginsKO logoKO27.8% margin vs TRNS's 2.0%
Stability / SafetyDHR logoDHRBeta 0.70 vs TRNS's 1.35, lower leverage
DividendsKO logoKO2.5% yield, 56-year raise streak, vs DHR's 0.7%, (1 stock pays no dividend)
Momentum (1Y)JPM logoJPM+21.8% vs DHR's -11.5%
Efficiency (ROA)KO logoKO13.1% ROA vs JPM's 1.3%, ROIC 15.8% vs 4.5%

TRNS vs TMO vs JPM vs DHR vs A vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Biotech & Healthcare Stocks Theme

These companies are key players in the Biotech & Healthcare Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
TRNSTranscat, Inc.
FY 2025
Service
65.4%$217M
Distribution Service
34.6%$115M
TMOThermo Fisher Scientific Inc.
FY 2025
Consumables
41.9%$18.7B
Service
41.7%$18.6B
Instruments
16.4%$7.3B
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
DHRDanaher Corporation
FY 2025
Revenue from Contract with Customer, Measurement, Recurring
81.9%$20.1B
Revenue from Contract with Customer, Measurement, Nonrecurring
18.1%$4.4B
AAgilent Technologies, Inc.
FY 2025
Agilent CrossLab
41.9%$2.9B
Life Sciences and Applied Markets
39.2%$2.7B
Applied Markets
18.9%$1.3B
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

TRNS vs TMO vs JPM vs DHR vs A vs KO — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGA

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 842.9x TRNS's $333M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to TRNS's 2.0%. On growth, TRNS holds the edge at +15.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTRNS logoTRNSTranscat, Inc.TMO logoTMOThermo Fisher Sci…JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…A logoAAgilent Technolog…KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$333M$45.2B$280.3B$24.8B$7.2B$49.3B
EBITDAEarnings before interest/tax$40M$10.5B$81.4B$7.2B$1.8B$15.5B
Net IncomeAfter-tax profit$7M$6.9B$57.0B$3.7B$1.4B$13.7B
Free Cash FlowCash after capex$20M$6.7B$100.9B$5.3B$1.3B$12.6B
Gross MarginGross profit ÷ Revenue+32.6%+39.4%+60.0%+60.7%+53.0%+61.7%
Operating MarginEBIT ÷ Revenue+4.1%+17.8%+25.9%+21.0%+21.5%+29.3%
Net MarginNet income ÷ Revenue+2.0%+15.2%+20.4%+14.9%+19.6%+27.8%
FCF MarginFCF ÷ Revenue+5.9%+14.9%+36.0%+21.4%+17.4%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year+15.8%+6.2%+3.7%+10.0%+12.1%
EPS Growth (YoY)Latest quarter vs prior year-56.3%+11.3%+16.0%+9.8%+60.0%+18.2%
KO leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

JPM leads this category, winning 5 of 7 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 90% valuation discount to TRNS's 160.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs DHR's 35.21x — a lower PEG means you pay less per unit of expected earnings growth.

MetricTRNS logoTRNSTranscat, Inc.TMO logoTMOThermo Fisher Sci…JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…A logoAAgilent Technolog…KO logoKOThe Coca-Cola Com…
Market CapShares × price$852M$174.4B$896.0B$127.5B$36.7B$355.6B
Enterprise ValueMkt cap + debt − cash$976M$205.4B$1.50T$141.3B$38.2B$390.8B
Trailing P/EPrice ÷ TTM EPS160.11x26.46x16.00x35.73x28.41x27.18x
Forward P/EPrice ÷ next-FY EPS est.51.85x18.88x14.40x21.34x21.43x25.27x
PEG RatioP/E ÷ EPS growth rate12.53x0.90x35.21x1.93x2.43x
EV / EBITDAEnterprise value multiple24.76x18.86x18.36x18.63x21.64x26.39x
Price / SalesMarket cap ÷ Revenue2.57x3.91x3.20x5.19x5.28x7.42x
Price / BookPrice ÷ Book value/share2.83x3.31x2.47x2.44x5.47x10.40x
Price / FCFMarket cap ÷ FCF43.60x27.72x8.88x24.23x31.83x67.15x
JPM leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 5 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $2 for TRNS. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), DHR scores 7/9 vs A's 5/9, reflecting strong financial health.

MetricTRNS logoTRNSTranscat, Inc.TMO logoTMOThermo Fisher Sci…JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…A logoAAgilent Technolog…KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity+2.2%+13.2%+15.9%+7.1%+20.8%+41.1%
ROA (TTM)Return on assets+1.4%+6.4%+1.3%+4.5%+11.1%+13.1%
ROICReturn on invested capital+2.6%+7.5%+4.5%+5.9%+13.5%+15.8%
ROCEReturn on capital employed+3.3%+9.1%+8.9%+7.0%+14.5%+17.3%
Piotroski ScoreFundamental quality 0–9565757
Debt / EquityFinancial leverage0.43x0.76x2.60x0.35x0.50x1.33x
Net DebtTotal debt minus cash$124M$31.0B$599.0B$13.8B$1.6B$35.2B
Cash & Equiv.Liquid assets$5M$9.9B$343.3B$4.6B$1.8B$10.3B
Total DebtShort + long-term debt$129M$40.9B$942.4B$18.4B$3.4B$45.5B
Interest CoverageEBIT ÷ Interest expense2.81x5.89x0.74x18.13x15.72x10.70x
KO leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $8,449 for DHR. Over the past 12 months, JPM leads with a +21.8% total return vs DHR's -11.5%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs DHR's -4.5% — a key indicator of consistent wealth creation.

MetricTRNS logoTRNSTranscat, Inc.TMO logoTMOThermo Fisher Sci…JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…A logoAAgilent Technolog…KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date+59.7%-20.7%-0.5%-21.7%-5.5%+20.3%
1-Year ReturnPast 12 months+17.9%+13.4%+21.8%-11.5%+10.0%+17.2%
3-Year ReturnCumulative with dividends-1.0%-9.5%+138.2%-13.0%+12.0%+47.0%
5-Year ReturnCumulative with dividends+66.3%+1.4%+118.2%-15.5%-6.9%+65.6%
10-Year ReturnCumulative with dividends+769.1%+219.0%+465.8%+222.6%+206.2%+121.1%
CAGR (3Y)Annualised 3-year return-0.3%-3.3%+33.6%-4.5%+3.8%+13.7%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than TRNS's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs TMO's 72.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTRNS logoTRNSTranscat, Inc.TMO logoTMOThermo Fisher Sci…JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…A logoAAgilent Technolog…KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5001.35x0.91x0.94x0.70x1.06x-0.20x
52-Week HighHighest price in past year$94.76$643.99$337.25$242.80$160.27$84.04
52-Week LowLowest price in past year$50.23$385.46$262.71$160.93$108.35$65.35
% of 52W HighCurrent price vs 52-week peak+96.3%+72.9%+95.1%+74.2%+81.0%+98.3%
RSI (14)Momentum oscillator 0–10062.750.859.152.056.160.6
Avg Volume (50D)Average daily shares traded155K2.0M7.0M4.2M1.9M12.7M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: TRNS as "Buy", TMO as "Buy", JPM as "Buy", DHR as "Buy", A as "Buy", KO as "Buy". Consensus price targets imply 35.4% upside for TRNS (target: $124) vs 4.2% for KO (target: $86). For income investors, KO offers the higher dividend yield at 2.46% vs TMO's 0.36%.

MetricTRNS logoTRNSTranscat, Inc.TMO logoTMOThermo Fisher Sci…JPM logoJPMJPMorgan Chase & …DHR logoDHRDanaher Corporati…A logoAAgilent Technolog…KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$123.60$599.70$339.75$231.80$154.75$86.13
# AnalystsCovering analysts104261434048
Dividend YieldAnnual dividend ÷ price+0.4%+1.9%+0.7%+0.8%+2.5%
Dividend StreakConsecutive years of raises08159056
Dividend / ShareAnnual DPS$1.69$5.95$1.23$0.99$2.04
Buyback YieldShare repurchases ÷ mkt cap+0.1%+1.7%+3.9%+2.4%+1.2%+0.2%
KO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

KO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JPM leads in 2 (Valuation Metrics, Total Returns).

Best OverallThe Coca-Cola Company (KO)Leads 4 of 6 categories
Loading custom metrics...

TRNS vs TMO vs JPM vs DHR vs A vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is TRNS or TMO or JPM or DHR or A or KO a better buy right now?

For growth investors, Transcat, Inc.

(TRNS) is the stronger pick with 19. 2% revenue growth year-over-year, versus 1. 9% for The Coca-Cola Company (KO). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Transcat, Inc. (TRNS) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TRNS or TMO or JPM or DHR or A or KO?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus Transcat, Inc. at 160. 1x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Danaher Corporation's 35. 21x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — TRNS or TMO or JPM or DHR or A or KO?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -15. 5% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: TRNS returned +769. 1% versus KO's +121. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TRNS or TMO or JPM or DHR or A or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus Transcat, Inc. 's 1. 35β — meaning TRNS is approximately -775% more volatile than KO relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — TRNS or TMO or JPM or DHR or A or KO?

By revenue growth (latest reported year), Transcat, Inc.

(TRNS) is pulling ahead at 19. 2% versus 1. 9% for The Coca-Cola Company (KO). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -63. 7% for Transcat, Inc.. Over a 3-year CAGR, TRNS leads at 12. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TRNS or TMO or JPM or DHR or A or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus 1. 6% for Transcat, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 4. 0% for TRNS. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TRNS or TMO or JPM or DHR or A or KO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Danaher Corporation's 35. 21x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 51. 9x for Transcat, Inc. — 37. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRNS: 35. 4% to $123. 60.

08

Which pays a better dividend — TRNS or TMO or JPM or DHR or A or KO?

In this comparison, KO (2.

5% yield), JPM (1. 9% yield), A (0. 8% yield), DHR (0. 7% yield), TMO (0. 4% yield) pay a dividend. TRNS does not pay a meaningful dividend and should not be held primarily for income.

09

Is TRNS or TMO or JPM or DHR or A or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, TRNS: +769. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TRNS and TMO and JPM and DHR and A and KO?

These companies operate in different sectors (TRNS (Industrials) and TMO (Healthcare) and JPM (Financial Services) and DHR (Healthcare) and A (Healthcare) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TRNS is a small-cap high-growth stock; TMO is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; DHR is a mid-cap quality compounder stock; A is a mid-cap quality compounder stock; KO is a large-cap quality compounder stock. JPM, DHR, A, KO pay a dividend while TRNS, TMO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.